Grown Rogue International (GRIN) Stock Overview
A craft cannabis company, focuses on premium flower and flower-derived products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
GRIN Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
100% Patient Improvement in trial puts this $16M Biotech on the radar
Key Takeaways Hoth is a clinical-stage biotech with a diversified pipeline across oncology, neurology, and inflammation. Lead drug HT-001 targets cancer treatment related rashes, a multi-hundred-million-dollar niche where no approved therapies exist.
Grown Rogue International Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.62 |
| 52 Week High | CA$1.02 |
| 52 Week Low | CA$0.39 |
| Beta | -0.95 |
| 1 Month Change | 5.08% |
| 3 Month Change | 31.91% |
| 1 Year Change | -34.74% |
| 3 Year Change | 463.64% |
| 5 Year Change | 463.64% |
| Change since IPO | 113.79% |
Recent News & Updates
Revenues Not Telling The Story For Grown Rogue International Inc. (CSE:GRIN) After Shares Rise 27%
Jul 15
Why We're Not Concerned Yet About Grown Rogue International Inc.'s (CSE:GRIN) 29% Share Price Plunge
May 31Recent updates
Revenues Not Telling The Story For Grown Rogue International Inc. (CSE:GRIN) After Shares Rise 27%
Jul 15Why We're Not Concerned Yet About Grown Rogue International Inc.'s (CSE:GRIN) 29% Share Price Plunge
May 31Why We're Not Concerned Yet About Grown Rogue International Inc.'s (CSE:GRIN) 31% Share Price Plunge
Apr 03Is Now The Time To Put Grown Rogue International (CSE:GRIN) On Your Watchlist?
Feb 10Investors Interested In Grown Rogue International Inc.'s (CSE:GRIN) Revenues
Oct 26Why We're Not Concerned About Grown Rogue International Inc.'s (CSE:GRIN) Share Price
Jul 01Here's Why Grown Rogue International (CSE:GRIN) Has Caught The Eye Of Investors
Feb 22What Grown Rogue International Inc.'s (CSE:GRIN) P/E Is Not Telling You
Jan 24We Think Grown Rogue International (CSE:GRIN) Is Taking Some Risk With Its Debt
Oct 31Grown Rogue International's (CSE:GRIN) Earnings Offer More Than Meets The Eye
Oct 05Do Grown Rogue International's (CSE:GRIN) Earnings Warrant Your Attention?
Aug 31Grown Rogue International (CSE:GRIN) Has A Somewhat Strained Balance Sheet
Sep 17Does Grown Rogue International (CSE:GRIN) Have A Healthy Balance Sheet?
Jun 01Here's Why Grown Rogue International (CSE:GRIN) Has A Meaningful Debt Burden
Nov 10President J. Strickler Just Bought 5.4% More Shares In Grown Rogue International Inc. (CSE:GRIN)
Feb 11Shareholder Returns
| GRIN | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 12.7% | 16.5% | 1.6% |
| 1Y | -34.7% | -13.6% | 22.2% |
Return vs Industry: GRIN underperformed the Canadian Pharmaceuticals industry which returned -14% over the past year.
Return vs Market: GRIN underperformed the Canadian Market which returned 22.3% over the past year.
Price Volatility
| GRIN volatility | |
|---|---|
| GRIN Average Weekly Movement | 12.4% |
| Pharmaceuticals Industry Average Movement | 12.9% |
| Market Average Movement | 9.2% |
| 10% most volatile stocks in CA Market | 19.7% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: GRIN has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: GRIN's weekly volatility (12%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | n/a | Jesse Strickler | www.grownrogue.com |
Grown Rogue International Inc., a craft cannabis company, focuses on premium flower and flower-derived products. It produces a range of cultivars for consumers, which are classified as indicas, sativas, and hybrids. The company sells its products through dispensaries.
Grown Rogue International Inc. Fundamentals Summary
| GRIN fundamental statistics | |
|---|---|
| Market cap | CA$154.74m |
| Earnings (TTM) | CA$4.04m |
| Revenue (TTM) | CA$33.18m |
Is GRIN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GRIN income statement (TTM) | |
|---|---|
| Revenue | US$23.78m |
| Cost of Revenue | US$12.41m |
| Gross Profit | US$11.37m |
| Other Expenses | US$8.47m |
| Earnings | US$2.89m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.012 |
| Gross Margin | 47.80% |
| Net Profit Margin | 12.17% |
| Debt/Equity Ratio | 26.5% |
How did GRIN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/05 10:50 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Grown Rogue International Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Siddharth Rajeev | Fundamental Research Corp. |